60 Degrees Pharmaceuticals Inc has a consensus price target of $1.2, established from looking at the 4 latest analyst ratings. The last 1 analyst ratings were released from Ascendiant Capital on October 2, 2023. With an average price target of $2.4 between Ascendiant Capital, there's an implied 840.44% upside for 60 Degrees Pharmaceuticals Inc from these 1 analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/06/2024 | Buy Now | — | HC Wainwright & Co. | Edward White | — | Reiterates | → Neutral | Get Alert |
04/03/2024 | Buy Now | — | HC Wainwright & Co. | Edward White | — | Reiterates | → Neutral | Get Alert |
10/20/2023 | Buy Now | — | HC Wainwright & Co. | Edward White | — | Initiates | → Neutral | Get Alert |
10/02/2023 | Buy Now | 840.44% | Ascendiant Capital | Lucas Ward | → $2.4 | Initiates | → Buy | Get Alert |
The latest price target for 60 Degrees (NASDAQ:SXTP) was reported by HC Wainwright & Co. on June 6, 2024. The analyst firm set a price target for $0.00 expecting SXTP to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for 60 Degrees (NASDAQ:SXTP) was provided by HC Wainwright & Co., and 60 Degrees reiterated their neutral rating.
There is no last upgrade for 60 Degrees
There is no last downgrade for 60 Degrees.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 60 Degrees, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 60 Degrees was filed on June 6, 2024 so you should expect the next rating to be made available sometime around June 6, 2025.
While ratings are subjective and will change, the latest 60 Degrees (SXTP) rating was a reiterated with a price target of $0.00 to $0.00. The current price 60 Degrees (SXTP) is trading at is $0.26, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.